在[99mTc]Tc-MAA SPECT/CT精准肝放射性栓塞治疗计划中减少SPECT与CT的配准误差
本研究通过仿真与临床数据评估两种基于肝脏的配准方案在减少静态[99mTc]Tc-MAA SPECT与CT之间配准误差的效果。仿真研究纳入70个XCAT体模,临床研究分析16例患者数据,比较配准前后不同感兴趣区的平均计数密度、归一化互信息、肺分流分数、肿瘤与正常肝比值及基于分区模型的最大注射活度。结果显示配准可显著降低肺分流分数估计误差、提高肿瘤与正常肝比值,并可能改变患者可治疗性及最大注射活度。
要点
- 配准可减少[99mTc]Tc-MAA SPECT与CT的空间不匹配,改善剂量学估计。
- 配准对肺分流分数的改善幅度大于对肿瘤与正常肝比值的改善。
- 配准后部分患者的最大注射活度可能改变,个别患者可能从不可治疗转为可治疗。
核心结论
- 静态[99mTc]Tc-MAA SPECT与对应CT之间的配准是可行的,可减少空间不匹配并改善剂量学估计。
- 配准对肺分流分数的改善大于对肿瘤与正常肝比值的改善,该方法可能改善患者筛选和个体化治疗计划。
研究设计与样本
- 仿真研究:建模70个XCAT体模,使用SIMIND蒙特卡罗程序和OS-EM算法生成投影并重建,模拟低剂量CT用于衰减校正、肺和肝分割,模拟增强CT用于肿瘤和灌注肝分割。
- 临床研究:分析16例患者的[99mTc]Tc-MAA SPECT/低剂量CT和增强CT数据,这些数据存在观察到的SPECT与CT不匹配。
- 研究两种基于肝脏的配准方案:将SPECT配准到低剂量CT/增强CT,以及反向配准。
主要发现
- 仿真研究中,与配准前相比,配准显著降低了所有感兴趣区的平均计数密度估计误差、肺分流分数(方案1:-100.28%,方案2:-101.59%)、肿瘤与正常肝比值(方案1:-7.00%,方案2:-5.67%)以及最大注射活度(方案1:-3.22%,方案2:-2.40%)。
- 临床研究中,与配准前相比,方案1降低肺分流分数33.68%并提高肿瘤与正常肝比值14.75%,方案2降低肺分流分数38.88%并提高肿瘤与正常肝比值6.28%。
- 配准后,1例患者可能从90Y放射性栓塞不可治疗转为可治疗,其他患者的最大注射活度可能改变高达25%。
- 两项研究中,配准后SPECT与CT之间的归一化互信息均显著增加。
关键数值与推荐
- 仿真研究中,方案1降低肺分流分数估计误差100.28%,方案2降低101.59%。
- 仿真研究中,方案1降低肿瘤与正常肝比值估计误差7.00%,方案2降低5.67%。
- 仿真研究中,方案1降低最大注射活度估计误差3.22%,方案2降低2.40%。
- 临床研究中,方案1降低肺分流分数33.68%并提高肿瘤与正常肝比值14.75%;方案2降低肺分流分数38.88%并提高肿瘤与正常肝比值6.28%。
- 配准后1例患者可能从90Y放射性栓塞不可治疗转为可治疗,其他患者最大注射活度可能改变高达25%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Respiration and body movement induce misregistration between static [99mTc]Tc-MAA SPECT and CT, causing lung shunting fraction (LSF) and tumor-to-normal liver ratio (TNR) errors for 90Y radioembolization planning. We aim to alleviate the misregistration between [99mTc]Tc-MAA SPECT and CT using two registration schemes on simulation and clinical data. METHODS: In the simulation study, 70 XCAT phantoms were modeled. The SIMIND Monte Carlo program and OS-EM algorithm were used for projection generation and reconstruction, respectively. Low-dose CT (LDCT) at end-inspiration was simulated for attenuation correction (AC), lungs and liver segmentation, while contrast-enhanced CT (CECT) was simulated for tumor and perfused liver segmentation. In the clinical study, 16 patient data including [99mTc]Tc-MAA SPECT/LDCT and CECT with observed SPECT and CT mismatch were analyzed. Two liver-based registration schemes were studied: SPECT registered to LDCT/CECT and vice versa. Mean count density (MCD) of different volumes-of-interest (VOIs), normalized mutual information (NMI), LSF, TNR, and maximum injected activity (MIA) based on the partition model before and after registration were compared. Wilcoxon signed-rank test was performed. RESULTS: In the simulation study, compared to before registration, registrations significantly reduced estimation errors of MCD of all VOIs, LSF (Scheme 1: - 100.28%, Scheme 2: - 101.59%), and TNR (Scheme 1: - 7.00%, Scheme 2: - 5.67%), as well as MIA (Scheme 1: - 3.22%, Scheme 2: - 2.40%). In the clinical study, Scheme 1 reduced 33.68% LSF and increased 14.75% TNR, while Scheme 2 reduced 38.88% LSF and increased 6.28% TNR compared to before registration. One patient may change from 90Y radioembolization untreatable to treatable and other patients may change the MIA up to 25% after registration. NMI between SPECT and CT was significantly increased after registrations in both studies. CONCLUSION: Registration between static [99mTc]Tc-MAA SPECT and corresponding CTs is feasible to reduce their spatial mismatch and improve dosimetric estimation. The improvement of LSF is larger than TNR. Our method can potentially improve patient selection and personalized treatment planning for liver radioembolization.
引用
- Lu Z, Chen G, Jiang H, et al. SPECT and CT misregistration reduction in [99mTc]Tc-MAA SPECT/CT for precision liver radioembolization treatment planning. Eur J Nucl Med Mol Imaging. 2023. PMID: 36877236. doi:10.1007/s00259-023-06149-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。